NCT00405197 MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study Status COMPLETED Phase NA
NCT00385931 Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin Status COMPLETED Phase PHASE3
NCT00385658 Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome Status COMPLETED Phase PHASE4
NCT00368095 Rajavithi Health Promotion Project (Population Base Cohort) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00362765 Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study Status TERMINATED Phase PHASE2/PHASE3
NCT00361868 Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI Status TERMINATED Phase PHASE3
NCT00358033 Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic Status COMPLETED Phase PHASE3
NCT00357955 Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients Status COMPLETED Phase NA
NCT00350038 Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions Status COMPLETED Phase PHASE4
NCT00346697 Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients Status COMPLETED Phase PHASE4
NCT00345657 Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care Status COMPLETED Phase PHASE4
NCT00345410 Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia Status COMPLETED Phase PHASE2
NCT00344370 Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia Status COMPLETED Phase PHASE3
NCT00344175 Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors Status COMPLETED Phase PHASE3
NCT00337415 MK0354 Clinical Efficacy and Tolerability Study (0354-004) Status TERMINATED Phase PHASE2
NCT00330785 Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia Status COMPLETED Phase PHASE3
NCT00326326 Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes. Status COMPLETED Phase PHASE2
NCT00325780 Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia Status COMPLETED Phase PHASE3